WittKieffer Converge Cast

Converge Cast | A Physician's Prescription for the Business of Healthcare: Gaurov Dayal, M.D.

In this episode of WittKieffer’s Converge Cast, Dr. Gaurov Dayal, Chief Executive Officer of Axia Women’s Health, talks with WittKieffer's Shelly Carolan and Linda Komnick about his commitment to revolutionizing healthcare in the U.S. with appreciation for both its business challenges – and the opportunities that exist.
As a physician, Dr. Dayal has always mixed a passion for helping others with a fascination for finance, economics, and the dollars and cents of running a business. Medicine is more of an "individual sport and business is a "team sport," he says, but they can coexist and inform each other for the benefit of patients and healthcare delivery organizations. A challenge for some physicians-turned-leaders: getting comfortable with ambiguity. "It definitely requires stepping out of your comfort zone and the need that many of us as physicians have to control every variable," he says. "You just cannot do that in business."
Dr. Dayal is an optimist about the changes coming for healthcare, including the incorporation of artificial intelligence. It's not only a means of improving healthcare and the business of healthcare, it also empowers patients to take control over their own health and well-being.

Converge Cast | Investing in Innovation Around True Value-Based Care: Anna Haghgooie

This episode of WittKieffer’s Converge Cast focuses on the transformative potential of value-based care. Our guest, Anna Haghhooie, shares her insight on investment in and innovation around “true” value-based care, which provides holistic and viable models of integrated care for patients and populations.  An eternal optimist, as well as seasoned operator and investor, she is actively pursuing her North Star in healthcare – to marry care efficiency and cost-effectiveness with human-to-human engagement.  Anna is Managing Director of Valtruis, a unique Welsh Carson Anderson & Stowe platform company that invests in and partners with disruptive leaders whose mission is to break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality, and radically improve the patient experience.
Speaking with WittKieffer’s Michael Castleman and Shelly Carolan, Anna explains how most current VBC models operate on a "chassis of legacy infrastructure," which hampers innovation and inhibits sustainable approaches. Innovation around VBC, shesays, will likely come from well-funded entrepreneurs willing to absorb risk and invest in alternate provider/payer/patient strategies.

Converge Cast | Scaling Innovation from Within the Healthcare Ecosystem: Amir Dan Rubin

Amir has spent his career seeking novel ways to increase access to care, cut costs, and advance population health. "The best innovation happens when you can innovate or disrupt from within the ecosystem," he says. Amidst the backdrop of  conventional health systems and organizations, there is a remarkable surge in innovation.  Notably, he observes transformations fueled by creative partnerships and inspired by the change taking place around them.
In this episode of WittKieffer's Converge Cast podcast series, Rubin talks with WittKieffer's Michael Castleman and Shelly Carolan discuss the evolving and increasingly convergent roles of value-based care, new healthcare entrants, and digital health, as well opportunities and challenges of start-ups in today's market. Questions they consider:
How do you enable innovative healthcare solutions with so many stakeholders-namely consumers, employers, clinicians and payers?
In this current market, what makes an attractive, deserving healthcare investment?
What role do insurers play in innovation?
What role will AI and related technologies play in healthcare's future?
To this last question, Rubin considers himself a "techno-optimist" – and it's clear he's an optimist on the potential for future with better, cheaper, more available healthcare.

Converge Cast | A Purposeful Path Toward Patient Centricity: Anthony Yanni, M.D.

In this conversation – the first episode of WittKieffer's Converge Cast series dedicated to exploring ideas that bring people and organizations across the Quality of Life Ecosystem together – Dr. Yanni shares his hopeful vision for patient centricity with Shelly Carolan, Managing Partner of Investor-Backed Healthcare for WittKieffer, and Stephen Brengle, the firm's Managing Director for Pharmaceuticals and Biotechnology, North America. They explore questions central to the success of patient centricity efforts:
What does patient centricity really mean?
How can organizations create cultures that foster and operationalize their patient centricity imperatives?
How can organizations better collaborate? What role will technology play?
The journey has really just begun, Dr. Yanni believes: "The impact across industry has yet to be maximized. The sharing of best practices still needs to happen. Everyone needs to be moving toward this."